Distalmotion targets ASC robotic gynecology programs with FDA filing [Yahoo! Finance]
Vicarious Surgical Inc. Class A (RBOT)
Company Research
Source: Yahoo! Finance
Dive Brief: Distalmotion has submitted a 510(k) application to expand the label of its Dexter robotic surgery system in the U.S., the company said Wednesday. The company aims to expand use of Dexter in gynecological indications, strengthening its push to support ambulatory surgical centers that want to perform more outpatient procedures. Distalmotion has identified ASCs, which may have less space, resources and infrastructure than hospitals, as sites of care where Dexter could have an advantage over existing surgical robots. Dive Insight: The Food and Drug Administration has cleared Dexter for use in gallbladder, hysterectomy and hernia repair procedures. Distalmotion's new filing covers sacrocolpopexy, sacrocervicopexy and endometriosis resection. Sacrocolpopexy and sacrocervicopexy are similar procedures that treat pelvic organ prolapse. Endometriosis resection removes tissue growing outside the uterus. Distalmotion CEO Greg Roche said in a statement that “expanding gyn
Show less
Read more
Impact Snapshot
Event Time:
RBOT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RBOT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RBOT alerts
High impacting Vicarious Surgical Inc. Class A news events
Weekly update
A roundup of the hottest topics
RBOT
News
- Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair [Yahoo! Finance]Yahoo! Finance
- Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia RepairGlobeNewswire
- Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing [Yahoo! Finance]Yahoo! Finance
- Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq ListingGlobeNewswire
- Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing [Yahoo! Finance]Yahoo! Finance
RBOT
Earnings
- 11/12/25 - Beat
RBOT
Sec Filings
- 3/23/26 - Form DEF
- 3/23/26 - Form 25-NSE
- 3/13/26 - Form PRE
- RBOT's page on the SEC website